Schröder, L., Rack, B., Sommer, H., Koch, J. G., Weissenbacher, T., Janni, W., . . . Scholz, C. (2016). Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined with Gemcitabine as an Adjuvant Treatment for High-Risk Early Breast Cancer: The SUCCESS-A Trial. Geburtshilfe Frauenheilkd.
Citação norma ChicagoSchröder, L., et al. "Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined With Gemcitabine As an Adjuvant Treatment for High-Risk Early Breast Cancer: The SUCCESS-A Trial." Geburtshilfe Frauenheilkd 2016.
MLA CitationSchröder, L., et al. "Toxicity Assessment of a Phase III Study Evaluating FEC-Doc and FEC-Doc Combined With Gemcitabine As an Adjuvant Treatment for High-Risk Early Breast Cancer: The SUCCESS-A Trial." Geburtshilfe Frauenheilkd 2016.